T cell immunity induced by a bivalent Salmonella-based CEACAM6 and 4-1BBL vaccines in a rat colorectal cancer model
Authors:
- 28 March 2017
- journal article
- Published by Spandidos Publications in Oncology Letters
- Vol. 13 (5) , 3753-3759
Abstract
The present study investigated the anti‑tumor mechanisms of recombinant non‑specific cross‑reacting antigen (CEACAM6) and 4‑1BB ligand (4‑1BBL) Salmonella‑based vaccines, and the effect that these vaccinations have on memory T cells and T helper (Th) cell polarization. Colon tumors were induced in rats via 1,2‑dimethylhydrazine (DMH) injections. Rats were then treated with injections of attenuated Salmonella typhimurium carrying pIRES‑CEACAM6, pIRES‑4‑1BBL or pIRES‑CEACAM6‑4‑1BBL. In total, 4 vaccine injections, one every other week, were administered during the 8 weeks subsequent to the DMH injection. Rats were sacrificed 18 weeks subsequent to the DMH injections, and the colons and spleens were collected for further analysis. Cluster of differentiation (CD) 45RO, interleukin (IL)‑4 and IL‑17 expression was analyzed in colon tumor tissues, and the expression of interferon (IFN)‑γ, CD3+, CD4+, CD8+, CD56+, forkhead/winged‑helix transcription factor box P3 (FOXP3+), IL‑4 and IL‑17 were analyzed in splenic tissues. Compared with the pIRES/SL3261 group, the pIRES‑CEACAM6‑4‑1BBL/SL3261 treatment group had a significantly higher number of CD45RO+ expressing tumor infiltrating lymphocytes and lower expression levels of IL‑4 and IL‑17. Splenic tissues from the same treatment group exhibited significantly increased expression of IFN‑γ, CD3+ and CD8+ and reduced expression levels of Foxp3, IL‑4 and IL‑7. CD56+ T cell expression was increased in all groups except for the group that received no vaccine. The present study concluded that the combined CEACAM6 and 4‑1BBL‑attenuated recombinant Salmonella vaccine was able to inhibit the growth of DMH‑induced colorectal tumors. This was mediated by generating an anti‑tumor immune response, increasing the number of of CD45RO+ memory T cells, decreasing the number of FOXP3+ cells and promoting Th1 polarization.Keywords
This publication has 24 references indexed in Scilit:
- Clinical impact of tumor-infiltrating CD45RO+ memory T cells on human gastric cancerOncology Reports, 2013
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008International Journal of Cancer, 2010
- IL-17 Promotes Tumor Development through the Induction of Tumor Promoting Microenvironments at Tumor Sites and Myeloid-Derived Suppressor CellsThe Journal of Immunology, 2010
- Memory CD8 T-cell compartment grows in size with immunological experienceNature, 2008
- Detection and Functional Analysis of Tumor Infiltrating T-Lymphocytes (TIL) in Liver Metastases from Colorectal CancerAnnals of Surgical Oncology, 2008
- FOXP3+ Regulatory T Cells Affect the Development and Progression of HepatocarcinogenesisClinical Cancer Research, 2007
- Estrogen Receptor α and β are Prognostic Factors in Non–Small Cell Lung CancerClinical Cancer Research, 2005
- Expression of CEACAM6 in Resectable Colorectal Cancer: A Factor of Independent Prognostic SignificanceJournal of Clinical Oncology, 2003
- Control of Regulatory T Cell Development by the Transcription Factor Foxp3Science, 2003
- The T Cell Receptor as a Multicomponent Signalling Machine: CD4/CD8 Coreceptors and CD45 in T Cell ActivationAnnual Review of Immunology, 1992